ARAY Stock Summary and Trading Ideas (Accuray | NASDAQ:ARAY)

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Accuray trades on the NASDAQ stock market under the symbol ARAY.

As of December 23, 2025, ARAY stock price declined to $0.83 with 1,852,643 million shares trading.

ARAY has a beta of 0.83, meaning it tends to be less sensitive to market movements. ARAY has a correlation of 0.07 to the broad based SPY ETF.

ARAY has a market cap of $94.07 million. This is considered a Micro Cap stock.

Last quarter Accuray reported $94 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $3 million and missed earnings estimates by -$.10.

In the last 3 years, ARAY traded as high as $4.30 and as low as $.81.

The top ETF exchange traded funds that ARAY belongs to (by Net Assets): VTI, IWM, VXF, IWO, FESM.

ARAY has underperformed the market in the last year with a price return of -55.1% while the SPY ETF gained +17.6%. ARAY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -53.6% and -16.0%, respectively, while the SPY returned +3.4% and +0.9%, respectively.

ARAY support price is $.85 and resistance is $.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARAY shares will trade within this expected range on the day.